Global Drug Screening Equipment Market Professional Survey Report 2019

2 Global Drug Screening Equipment Quarterly Market Size Analysis

• 2.1 Drug Screening Equipment Business Impact Assessment - COVID-19
  • 2.1.1 Global Drug Screening Equipment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Drug Screening Equipment Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Drug Screening Equipment Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Drug Screening Equipment Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Drug Screening Equipment Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Drug Screening Equipment Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Drug Screening Equipment Market
• 3.5 Key Manufacturers Drug Screening Equipment Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Drug Screening Equipment Segments, By Type

• 4.1 Introduction
  • 1.4.1 Immunoassay Analyzers
  • 1.4.2 Chromatography Instruments
  • 1.4.3 Breath Analyzers
  • 1.4.4 Other
• 4.2 By Type, Global Drug Screening Equipment Market Size, 2019-2021
  • 4.2.1 By Type, Global Drug Screening Equipment Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Drug Screening Equipment Price, 2020-2021

5 Impact of Covid-19 on Drug Screening Equipment Segments, By Application

• 5.1 Overview
  • 5.5.1 Hospitals
  • 5.5.2 Research Institute
  • 5.5.3 Biotechnology & Pharmaceutical Companies
  • 5.5.4 Other
• 5.2 By Application, Global Drug Screening Equipment Market Size, 2019-2021
  • 5.2.1 By Application, Global Drug Screening Equipment Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Drug Screening Equipment Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Quest Diagnostics
  • 7.1.1 Quest Diagnostics Business Overview
  • 7.1.2 Quest Diagnostics Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.1.3 Quest Diagnostics Drug Screening Equipment Product Introduction
  • 7.1.4 Quest Diagnostics Response to COVID-19 and Related Developments
• 7.2 Abbott
  • 7.2.1 Abbott Business Overview
  • 7.2.2 Abbott Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.2.3 Abbott Drug Screening Equipment Product Introduction
  • 7.2.4 Abbott Response to COVID-19 and Related Developments
• 7.3 Roche
  • 7.3.1 Roche Business Overview
  • 7.3.2 Roche Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.3.3 Roche Drug Screening Equipment Product Introduction
  • 7.3.4 Roche Response to COVID-19 and Related Developments
• 7.4 Thermo Fisher
  • 7.4.1 Thermo Fisher Business Overview
  • 7.4.2 Thermo Fisher Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.4.3 Thermo Fisher Drug Screening Equipment Product Introduction
  • 7.4.4 Thermo Fisher Response to COVID-19 and Related Developments
• 7.5 Dragerwerk
  • 7.5.1 Dragerwerk Business Overview
  • 7.5.2 Dragerwerk Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.5.3 Dragerwerk Drug Screening Equipment Product Introduction
  • 7.5.4 Dragerwerk Response to COVID-19 and Related Developments
• 7.6 Mpd
  • 7.6.1 Mpd Business Overview
  • 7.6.2 Mpd Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.6.3 Mpd Drug Screening Equipment Product Introduction
  • 7.6.4 Mpd Response to COVID-19 and Related Developments
• 7.7 Siemens
  • 7.7.1 Siemens Business Overview
  • 7.7.2 Siemens Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.7.3 Siemens Drug Screening Equipment Product Introduction
  • 7.7.4 Siemens Response to COVID-19 and Related Developments
• 7.8 Express
  • 7.8.1 Express Business Overview
  • 7.8.2 Express Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.8.3 Express Drug Screening Equipment Product Introduction
  • 7.8.4 Express Response to COVID-19 and Related Developments
• 7.9 Shimadzu
  • 7.9.1 Shimadzu Business Overview
  • 7.9.2 Shimadzu Drug Screening Equipment Quarterly Production and Revenue, 2020
  • 7.9.3 Shimadzu Drug Screening Equipment Product Introduction
  • 7.9.4 Shimadzu Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Drug Screening Equipment Supply Chain Analysis
  • 8.1.1 Drug Screening Equipment Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Drug Screening Equipment Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Drug Screening Equipment Distribution Channels
  • 8.2.2 Covid-19 Impact on Drug Screening Equipment Distribution Channels
  • 8.2.3 Drug Screening Equipment Distributors
• 8.3 Drug Screening Equipment Customers

9 Key Findings

10 Appendix

• 10.1 About Us